Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.

Saved in:
Bibliographic Details
Title: Cytotoxic T Cells Drive Outcome in Inflammatory Dilated Cardiomyopathy.
Authors: Sikking MA; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., Harding D; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry (D.H., S.F., F.M.M.-B.), Queen Mary University of London, United Kingdom.; Barts Heart Centre, Barts Health NHS Trust, St Bartholomew's Hospital, London, United Kingdom (D.H., F.M.M.-B.)., Henkens MTHM; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands.; Department of Pathology (M.T.H.M.H., X.L.), Maastricht University Medical Center, the Netherlands.; Netherlands Heart Institute, Utrecht, the Netherlands (M.T.H.M.H.)., Stroeks SLVM; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands.; Department of Clinical Genetics (S.L.V.M.S., J.A.J.V.), Maastricht University Medical Center, the Netherlands.; Maastricht UMC+ European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) (S.L.V.M.S., J.A.J.V., S.R.B.H.).; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, Herestraat 49, University of Leuven, Belgium (S.L.V.M.S., S.R.B.H.)., Venner MFGHM; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., Nihant B; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., van Leeuwen REW; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., Fanti S; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry (D.H., S.F., F.M.M.-B.), Queen Mary University of London, United Kingdom., Li X; Department of Pathology (M.T.H.M.H., X.L.), Maastricht University Medical Center, the Netherlands., van Paassen P; Division Clinical and Experimental Immunology, Department of Internal Medicine (P.v.P.), Maastricht University Medical Center, the Netherlands., Knackstedt C; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., Brunner-la Rocca HP; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., van Empel VPM; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands., Verdonschot JAJ; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands.; Department of Clinical Genetics (S.L.V.M.S., J.A.J.V.), Maastricht University Medical Center, the Netherlands.; Maastricht UMC+ European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) (S.L.V.M.S., J.A.J.V., S.R.B.H.)., Marelli-Berg FM; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry (D.H., S.F., F.M.M.-B.), Queen Mary University of London, United Kingdom.; Centre for Inflammation and Therapeutic Innovation (F.M.M.-B.), Queen Mary University of London, United Kingdom.; Barts Heart Centre, Barts Health NHS Trust, St Bartholomew's Hospital, London, United Kingdom (D.H., F.M.M.-B.)., Heymans SRB; Department of Cardiology, Cardiovascular Research Institute Maastricht (M.A.S., M.T.H.M.H., S.L.V.M.S., M.F.G.H.M.V., B.N., R.E.W.v.L., C.K., H.-P.B.-L.R., V.P.M.v.E., J.A.J.V., S.R.B.H.), Maastricht University Medical Center, the Netherlands.; Maastricht UMC+ European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart) (S.L.V.M.S., J.A.J.V., S.R.B.H.).; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, Herestraat 49, University of Leuven, Belgium (S.L.V.M.S., S.R.B.H.).
Source: Circulation research [Circ Res] 2024 Dec 06; Vol. 135 (12), pp. 1193-1195. Date of Electronic Publication: 2024 Oct 21.
Publication Type: Letter
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0047103 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4571 (Electronic) Linking ISSN: 00097330 NLM ISO Abbreviation: Circ Res Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1524-4571
DOI:10.1161/CIRCRESAHA.124.325183